Company Profile
Celetrix was founded in Manassas, Virginia, USA in 2012, with a long-term focus on cell electroporation technology. Celetrix cell electroporation technology can be applied to immune cells (including T cells, NK cells, etc.), stem cells, nerve cells, various primary cells, and cell lines. In addition, the new generation of Celetrix electroporation can also be used for microbial electroporation such as bacteria and yeast, as well as for cell electrofusion to produce hybridoma cells for monoclonal antibody screening. We have detailed plans to assist clients in advancing gene editing, electroporation of CAR-T, electroporation of CAR-NK, and rapid mass production of antibodies.view more
- Main Products
- Address
- No. 188, East Section of Development Avenue
